Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
An observational study to describe the effectiveness, safety, and patient-reported outcomes (PROs) in participants with moderate to severe active rheumatoid arthritis (RA) in France receiving filgotinib in real-world setting.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
155 participants in 1 patient group
Loading...
Central trial contact
Galapagos Medical Information
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal